Skip to main content
Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
23.80
+0.76 (3.30%)
Dec 20, 2024, 4:00 PM EST - Market closed

Dianthus Therapeutics Revenue

Dianthus Therapeutics had revenue of $2.17M in the quarter ending September 30, 2024, with 135.06% growth. This brings the company's revenue in the last twelve months to $5.37M, up 51.41% year-over-year. In the year 2023, Dianthus Therapeutics had annual revenue of $2.83M, down -55.96%.

Revenue (ttm)
$5.37M
Revenue Growth
+51.41%
P/S Ratio
125.04
Revenue / Employee
$101,245
Employees
53
Market Cap
704.41M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20232.83M-3.59M-55.96%
Dec 31, 20226.42M4.94M334.76%
Dec 31, 20211.48M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

DNTH News

More News